Author Archives
-
Happy holidays
The strange year 2020 is coming to an end. It has been a challenging one for all of us. A year of digital meetings, a year without socializing at Lysebu or at workshops. Not the best conditions for networking. Nevertheless,… Read More ›
-
13 mill. NOK to the Norwegian EXercise and Atrial Fibrillation (NEXAF) study!
The Norwegian EXercise and Atrial Fibrillation Study (NEXAF) is a collaborative project within afib.no addressing research questions related to exercise and atrial fibrillation. The project includes three main work packages: Work package 1 is a randomized controlled trial of a… Read More ›
-
Omega-3 fatty acids may increase the risk of atrial fibrillation
Several afib.no network members are involved in the OMega-3 fatty acids in Elderly with Myocardial Infarction (OMEMI) trial, investigating the effect of n-3 polyunsaturated fatty acids in patients aged 70-82 with recent myocardial infarction. The results were presented by Are… Read More ›
-
4th annual meeting 2020
Thank you all for your contribution to this year’s afib.no meeting! It was great to see that we had more participants this year than any previous year. We started out with a great talk by Renate Schnabel about Atrial fibrillation… Read More ›
-
High prevalence of atrial fibrillation in Norway
In a study recently published in Heart, afib.no network members investigated the incidence of atrial fibrillation (AF) for the entire Norwegian population ≥ 18 years from 2004 to 2014, by age and gender. The prevalence at the end of the… Read More ›
-
Network member Vegard Malmo wins KlinForsk prize
We congratulate Vegard Malmo on winning the prize for best thesis at KlinForsk’s webinar on “International Clinical Trials Day” May 20, 2020, with his thesis: Atrial Fibrillation and exercise. Read more here. (Norwegian page)
-
Network member Lars Elnan Garnvik defended his PhD thesis March 24, 2020.
Afib.no network member Lars Elnan Garnvik defended his thesis “Physical activity and cardiorespiratory fitness as determinants of atrial fibrillation incidence and prognosis. Observational findings from the HUNT study” for the degree of PhD at the Faculty of Medicine and Health… Read More ›
-
NOACs differ with regard to bleeding risk
Non-vitamin K antagonist Oral Anticoagulants (NOACs) have become the mainstay therapy for stroke prophylaxis in atrial fibrillation. Although shown equally or more safe and effective than warfarin, there is limited knowledge of the comparative effectiveness and safety of the NOACs…. Read More ›
-
Long-term ECG recording: findings and implications
Network member Jarle Jortveit and colleagues have investigated 1,262 long-term ECG recordings performed at Sørlandet Hospital Arendal, Norway, in the period 2017–18. The results were recently published in The Journal of the Norwegian Medical Association. The authors suggest that long-term ECG recording should… Read More ›
-
Left atrial volumes in the ACE 1950 study cohort
Network members from Bærum Hospital and Akershus University Hospital co-authored an article published by the European Heart Journal – Cardiovascular Imaging. The authors describe volumetric measurements of the left atrium with echocardiography in 3489 individuals and in a healthy subgroup… Read More ›
afib.no 